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ABSTRACT Methicillin-resistant Staphylococcus aureus (MRSA) strains are leading causes of hospital-acquired infections in the
United States, and clonal cluster 5 (CC5) is the predominant lineage responsible for these infections. Since 2002, there have been
12 cases of vancomycin-resistant S. aureus (VRSA) infection in the United States—all CC5 strains. To understand this genetic
background and what distinguishes it from other lineages, we generated and analyzed high-quality draft genome sequences for
all available VRSA strains. Sequence comparisons show unambiguously that each strain independently acquired Tn1546 and
that all VRSA strains last shared a common ancestor over 50 years ago, well before the occurrence of vancomycin resistance in
this species. In contrast to existing hypotheses on what predisposes this lineage to acquire Tn1546, the barrier posed by restric-
tion systems appears to be intact in most VRSA strains. However, VRSA (and other CC5) strains were found to possess a constel-
lation of traits that appears to be optimized for proliferation in precisely the types of polymicrobic infection where transfer
could occur. They lack a bacteriocin operon that would be predicted to limit the occurrence of non-CC5 strains in mixed infec-
tion and harbor a cluster of unique superantigens and lipoproteins to confound host immunity. A frameshift in dprA, which in
other microbes influences uptake of foreign DNA, may also make this lineage conducive to foreign DNA acquisition.
IMPORTANCE Invasive methicillin-resistant Staphylococcus aureus (MRSA) infection now ranks among the leading causes of
death in the United States. Vancomycin is a key last-line bactericidal drug for treating these infections. However, since 2002, van-
comycin resistance has entered this species. Of the now 12 cases of vancomycin-resistant S. aureus (VRSA), each was believed to
represent a new acquisition of the vancomycin-resistant transposon Tn1546 from enterococcal donors. All acquisitions of
Tn1546 so far have occurred in MRSA strains of the clonal cluster 5 genetic background, the most common hospital lineage caus-
ing hospital-acquired MRSA infection. To understand the nature of these strains, we determined and examined the nucleotide
sequences of the genomes of all available VRSA. Genome comparison identified candidate features that position strains of this
lineage well for acquiring resistance to antibiotics in mixed infection.
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Twelve cases of vancomycin-resistant Staphylococcus aureus(VRSA) infection have been reported in the United States
since 2002 (1). Each is believed to represent a de novo acquisition
of Tn1546 from enterococci in a clonal cluster 5 (CC5)
methicillin-resistant S. aureus (MRSA) (2). CC5 includes strains
of pulsed-field gel electrophoresis (PFGE) types USA100 and
USA800 and also contains the UK-EMRSA-3 strain, the New
York-Japan clone, the Pediatric clone, the Rhine-Hesse epidemic
strain, and the Canadian MRSA-2 strain (3).
CC5 strains are leading causes of hospital-associated S. aureus in-
fection in the United States (4). They predominate in burn units,
among blood isolates, and in intensive care nurseries (5–8) and rank
among the leading causes of S. aureus infection globally (9, 10). CC5
strains were identified among early methicillin-resistant isolates in
the 1960s (11) and were shown to have acquired staphylococcal cas-
sette chromosome mec (SCCmec) at least 23 separate times (10).
MRSA strains with reduced susceptibility to glycopeptide antibiotics
(vancomycin- or glycopeptide-intermediate S. aureus [VISA or
GISA, respectively]) (12)ariseby spontaneouspointmutations incell
wall synthesis genes (13) and are almost always CC5 (14).
RESEARCH ARTICLE
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Each of the 12 U.S. VRSA strains are believed to have resulted
from acquisition of Tn1546 from enterococci during the course of
infection (15). Tn1546 confers the VanA phenotype. Curiously,
most of the Tn1546were from an Enterococcus faecalis donor (15–
17), as opposed to the more common vancomycin-resistant En-
terococcus faecium (18). Nine VRSA strains arose in southeast
Michigan, where Tn1546 transfer was mediated by a broad-host-
range conjugative Inc18 plasmid (15–17, 19).
The repeated acquisition of vancomycin resistance by CC5,
along with its involvement in the early acquisition of methicillin
resistance and resistance to other antibiotics (11), suggests that it
is genetically or biologically predisposed to horizontal acquisition
of resistance and possibly other genes. Such transfer requires that
donors and recipients coexist intimately in a mixed community,
and that they achieve a population size that allows them to over-
come inefficiencies and obstacles to transfer, genetic element es-
tablishment, and resistance expression. Thus, it was of interest to
examine VRSA genomes for barriers to entry of foreign DNA as
well as for traits that could foster their existence inmixed infection
with potential resistance donors. We therefore generated high-
quality draft genome sequences of the available 12 CC5 VRSA
isolates from the first 11 VRSA cases in the United States and
examined them for traits thatmay have predisposed this lineage to
vancomycin resistance acquisition.
RESULTS
North American CC5 phylogeny. We determined a core gene
sequence-based phylogeny for VRSA, based on 1,822 single-copy
orthologs present in all genomes (Fig. 1). Strains do not cluster
based on site or time of isolation (Fig. 1), supporting their inde-
pendent development into VRSA. Strain VRS3a, isolated in New
York in 2004 (the only PFGE type USA800 strain) is the most
divergent. MRSA strain JH1 and its GISA derivative JH9, which
arose during antimicrobial therapy (13, 20), are nested deeply
within theVRSA. This phylogeny shows that all VRSA strains stem
from a monophyletic source, supporting the hypothesis that they
harbor a trait or traits that predispose them for vancomycin resis-
tance acquisition or expression.
Tn1546 haplotype network. To determine whether Tn1546
evolved along a path different from the rest of the chromosome (as
would be expected if Tn1546 were repeatedly, independently ac-
quired as opposed to having been acquired once and then passed
along vertically with the rest of the chromosome), Tn1546 se-
quences were compared, and their relationships to each other and
to possible donor elements were calculated (17, 19) (Fig. 2).
Tn1546 sequences segregate regionally, as opposed to temporally
(e.g., transposons from strains isolated in New York, Pennsylva-
nia, and Delaware [strains VRS2, VRS3a, and VRS11a or VRS11b
{VRS11a/b}]) share features with each other that are not shared by
strains from Michigan (e.g., strains VRS1 and VRS4), consistent
with an independent acquisition model (Fig. 2). All Tn1546 se-
quences fromMichiganVRSA strains form a tight cluster with few
single-nucleotide polymorphisms (SNPs). Tn1546 in E. faecalis
VRE5, coisolated with VRS5 (17), possesses a 491-bp duplication
missing in VRS5, suggesting that either VRE5 is not the Tn1546
donor or that the duplication occurred in the donor after transfer.
FIG 1 Phylogeny based on single-copy core orthologs (n  1,822). Phylogeny showing the relationship of VRSA genomes to other completely sequenced
S. aureus genomes. The date (month/day/year) and geographic location of the VRSA strain andmultilocus sequence type (MLST) are indicated in the expanded
section.MI,Michigan; PA, Pennsylvania; NY, New York; DE, Delaware;MD,Maryland; JP, Japan; NIR, Northern Ireland. Bootstrap values are indicated at each
node. Scale bars correspond to number of changes per site.
Kos et al.
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Tn1546 of candidate enterococcal donor VRE4 is identical to that
in VRS4, as well as to transposons in putative enterococcal donor
strains VRE6 and VRS6. Tn1546 from the plasmid in putative
donor VRE9 differs from that in VRS9 by a single SNP (Fig. 2).
Tn1546 of strains VRS2 and VRS3a were reported to possess
insertions of IS1251 between vanS and vanH, as well as copies of
IS1216within orf1 that are inverted in the two strains (21, 22). The
Tn1546portions of these composite elements have 4 SNPs in com-
mon, distinguishing them from the VRS1 prototype and support-
ing their origination from a closely related source. Tn1546 of
strain VRS11a/b shares a SNPwith strains VRS2 and VRS3a, plac-
ing it between the New York and Pennsylvania elements, and the
Michigan transposons. VRS11a/b possesses an ISE.faecalis1
(ISEf1) insertion in the intergenic region between vanX and vanY
(Fig. 2). VRS11a and VRS11b also possess a common SNP that is
not found in other strains. Finally, even though isolated from a
single patient, a third SNP distinguishes VRS11b from VRS11a,
probably the result of microevolution within the patient.
Comparison of the Tn1546 haplotype network to the single-
copy core gene phylogeny showed that that there was little con-
gruence and that the Tn1546 haplotype network was a poor pre-
dictor of core gene phylogeny (P  0.0001 by the Shimodaira-
Hasegawa test [23]). Phylogenies based upon typing schemes for
the hypervariable repeat regions of clumping factor B (clfB), co-
agulase (coa), and protein A (spa) and based on SCCmec and agr
loci also failed to show a consistent line of VRSA strain descent
(see Table S1A and Fig. S1A, S1B, and S1C in the supplemental
material). The results of each analysis strongly support the model
that each VRSA isolate arose as the result of an independent trans-
poson acquisition.
Diversity in plasmid content and Tn1546 location. Tn1546
resides on plasmids in all VRSA strains, not on the chromosome
(even though the chromosome is much larger and would seem to
be a more probable insertion target). Each VRSA strain harbors
plasmids of enterococcal and staphylococcal origin, and in some
cases, cointegrates of the two (Fig. 3), highlighting their history of
cooccurrence in mixed infections with enterococci. Plasmids in-
volved in Tn1546 acquisition vary. Strains VRS1 (24), VRS8,
VRS9, and VRS11a/b possess large portions of the staphylococcal
plasmid pSK41. pSK41 has been shown to enhance gene transfer
from E. faecalis strains harboring pheromone-responsive plasmid
pAD1 because of pheromone cross talk (25) and the pheromone
encoded by a pSK41 gene is detected in the supernatant of strain
VRS1 (15). The transposition of Tn1546 onto pSK41, with con-
comitant loss of the enterococcal donor plasmid, was previously
reported to have occurred in strain VRS1 (24). In strains VRS8
and VRS9, Tn1546 also transposed to pSK41, but at unique sites.
Strains VRS2, VRS3a, VRS4, VRS5, VRS6, VRS7, and VRS10 pos-
sess small fragments with sequence identity to pSK41, but these
identities do not include pSK41 traH, the gene encoding the en-
terococcal plasmid pAD1 pheromone precursor.
FIG 2 Haplotype network of Tn1546 sequences. Numbering of the nucleo-
tide changes refers to the position in sequence in comparison to the prototyp-
ical Tn1546(GenBank accession no. M97297).
FIG 3 Plasmid sequences in VRSA. Heat map showing the extent of occur-
rence of known enterococcal (graded green shades) and staphylococcal plas-
mids (graded yellow to red) (based on detail in Table S5 in the supplemental
material). Plasmids that are definitely present in the strains are indicated by
squares outlined with a thick black border. The plasmid on which Tn1546
resides is indicated by a white v, and superscript letters a through g denote
unique insertion sites. pLW043* is the pSK41 homolog into which Tn1546
inserted. pWZ909 is the prototype Inc18 enterococcal plasmid involved in
vancomycin resistance transfer. pN315 and pUSA300 were shown in one col-
umn, as these plasmids are nearly identical.
Vancomycin-Resistant Staphylococcus aureus
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Strains VRS2 and VRS3a acquired Tn1546 on large (100-kb)
enterococcal plasmids, which were retained (21, 22). Identical se-
quences surround Tn1546 in both strains, indicating a closely re-
lated source. These megaplasmids likely represent cointegrates of
enterococcal plasmids pS177, p5753cB, and possibly pLG2
(Fig. 3). Mosaic plasmid structures are common in enterococci
(26). Interestingly, the plasmid content of strainVRS7 is similar to
that of strain VRS2, but with Tn1546 remaining on the broad-
host-range Inc18 donor plasmid (Fig. 3). In addition to VRS7,
VRS4 and VRS5 also retain Tn1546 on the Inc18 enterococcal
donor plasmid (17). The sequence of the Inc18 plasmid in VRS10
was completed and found to possess an additional 2.97-kb trans-
poson insertion not present in the others. In VRS4, VRS5, VRS7,
and now VRS10, the location of Tn1546 in the Inc18 donor plas-
mid is identical, highlighting the role of this common element in
theMichigan outbreak (16). In VRS6, Tn1546was known to have
transposed onto an S. aureus resident plasmid, with loss of the
donor plasmid (16). In this strain, insertion occurred in a novel
plasmid of apparent staphylococcal origin.
Strains VRS11a andVRS11b originated from a single patient in
Delaware, and each strain possesses a cointegrate of enterococcal
and staphylococcal plasmids (see Fig. S2 in the supplemental
material) as confirmed by PCR. The cointegrate is a fusion of
S. aureus plasmid pLUH02 (including genes for beta-lactamase,
enterotoxin, cadmium resistance, and replication), and an entero-
coccal pCF10-like plasmid carrying pheromone-responsive genes.
Tn1546 resides on this fusion plasmid in a location that is identical
in both strains (Fig. S2).
No functional lesions identifiable in restriction-
modification systems of most VRSA strains.The Sau1 restriction
system (27) and a type III-like restriction system (28) represent
known barriers to foreignDNA entry. The Sau1 restriction system
consists of an endonuclease, HsdR, encoded by a gene distant
from two pairs of specificity and modification subunits, which
occur on genomic islands Sa and Sa (27). In VRSA, most
Sau1 restriction systems are intact (Fig. 4A). Strain VRS3a pos-
sesses a mutation in the hsdR Sau1 endonuclease gene that results
in a large truncation of the HsdR subunit (see Fig. S2B in the
supplemental material). Several polymorphisms in the Sa
sau1CC5 hsdM1 copy of the HsdM modification subunit were
observed (Fig. 4A), most representing minor amino acid changes.
However, in the Sa copy of HsdM in strain VRS9, a frameshift
occurs, caused by an adenine duplication at nucleotide position
1213, which truncates the primary translation product (Fig. 4A).
In the Sa sau1CC5 hsdS1 encoded specificity subunit of
VRS11a/b, a nonsensemutation occurs in the second codon, likely
causing a large truncation (Fig. 4A). In contrast to polymorphic
copies in Sa, only one polymorphism was noted in the Sa
copies of HdsS andHsdM subunits (Fig. 4A). That polymorphism
corresponds to an addition of 3 amino acids to the carboxy termi-
nus of HsdS in strain VRS2, which seems unlikely to alter func-
tion. Lack of mutations in the Sa genes for HsdM and HsdS, as
well as in most copies of counterparts in the Sa island, indicate
that Sau1 is likely functional in all VRSA strains, except for VRS3a.
A nonsense mutation in the type III-like restriction system has
been reported to occur in Japanese CC5 strains (28). The impact
of this specific mutation on function is unclear, although the type
III-like restriction system clearly poses a barrier to DNA uptake
(28). Only strain VRS10 possesses a polymorphism in this locus
(MQS_01626; a point change that creates a nonsense mutation in
the 12th codon) that is likely to be of functional consequence
(Fig. 4A). Strain VRS9 possesses a polymorphism that leads to a
conservative N89D amino acid substitution. Otherwise, the type
III-like restriction systems of all other VRSA strains appear to be
intact.
Frameshift in dprA in all VRSA strains except VRS3a. One
coding difference related to DNA metabolism that stood out in
comparison of CC5 to non-CC5 genomes was an adenine dupli-
cation at positions 333 and 334 in dprA. This duplication intro-
duces a truncating frameshift (Fig. 4B), potentially eliminating or
alteringDprA function. This changewas found in all NorthAmer-
ican CC5 strains except strain VRS3a. DprA influences DNA
transformation efficiency in Bacillus subtilis (29). In addition to
identifying potential loss-of-functionmutations, such as the dprA
frameshift, we also searched for other potentially function-
altering nonsynonymous-codon-changing SNPs unique to North
American CC5 strains. We identified 45 SNPs common to all ex-
cept the most divergent strain, VRS3a (see Table S2 in the supple-
mental material).
VRSA strains possess polymorphisms in the agr locus. Simi-
lar to recent observations for phage 80/81 isolates of S. aureus that
were prevalent in hospitals in the early 1990s (30), several VRSA
strains (VRS1, VRS2, and VRS8 [see Fig. S1C in the supplemental
material]) possess lesions in a key global regulator of virulence, agr
(31). The agr locus is known to attenuate during infection (32),
and this parallels reduced vancomycin susceptibility (33, 34).
CC5 gene content differences include lack of a bacteriocin
operon and presence of genes for diverse superantigens. We
next examined North American CC5 strains, including VRSA, for
differences in gene content that could promote coexistence in
polymicrobic infection (see Table S3A and S3B in the supplemen-
tal material). Most of the variable gene content unique to the
North American CC5 strains occurs within the Sa island (35,
36) (Table S3A; Fig. 5). Of potentially high importance, an operon
(bsa) encoding a lantibiotic bacteriocin (active against other
Gram-positive bacterial species [37, 38]), is absent in all members
of the CC5 lineage. Instead, this island contains a unique cluster of
enterotoxin genes (Fig. 5). Interestingly, this pattern—the absence
of the bacteriocin operon and the presence of nearly identical
complement of superantigens—also occurs in the Sa pathoge-
nicity islands in the EMRSA-15 and MRSA252/EMRSA-16 lin-
eages that are prevalent in hospitals in the United Kingdom (39),
even though the genetic backgrounds are highly dissimilar
(Fig. 5). This suggests active selection for this version of Sa in
the hospital environment. The main difference in Sa islands in
strains from the United States and United Kingdom is a polymor-
phism that breaks the seu superantigen gene into ent1 and ent2
pseudogenes in the CC5 strains. In contrast to a previous hypoth-
esis (40), our results indicate that the complete seu gene is in the
ancestral state, and a deletion at the base of the CC5 clade created
the pseudogenes. The North American CC5 SA island also in-
cludes leukocidin genes, which encode a toxin that prevents
phagocytic clearance (41, 42). CC5 strains lack the phage carrying
the Panton-Valentine leukocidin (PVL) toxin (43) gene. Synteny
analysis independently confirmed each of the above differences
and identified other changes in gene position of unknown conse-
quence (see Fig. S3 in the supplemental material).
Lipoproteins unique to CC5. S. aureus strains are known to
harbor clusters of lipoprotein genes typically at four locations in
the chromosome—within a Sa element and at three other sites
Kos et al.
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FIG 4 Restriction systems and dprA in VRSA. (A) (1) Alignment of inferred primary translation products of genes encoding the Sau1 restriction nuclease
subunit (HsdR) compared to the CC5 strain originating in Japan, S. aureusN315. Polymorphisms are highlighted. Periods in blocks of sequence denote stretches
that are identical and not shown.Numbers above the sequences represent the amino acid position in the prototype, fromwhich distances represented by dots can
be discerned. (2) Alignment of inferred primary translation products of genes encoding the modification (HsdM) and specificity (HsdS) subunits in the Sa
island. The locations of restriction-modification subunits relative to other key genes are indicated. (3) Alignment of inferred primary translation products of
genes encoding the specificity (HsdS) subunits in the Sa island. No polymorphisms occur in the Sa HsdM-encoding gene (not shown). (4) Alignment of
inferred primary translation products of genes encoding the type III-like restriction system compared to those of N315 and the CC8 S. aureus NCTC8325
prototype sequence. (B) Alignment of inferred primary translation products of dprA genes of VRSA. VRS3a is the only isolate that encodes a dprA product
identical to that encoded by the Japanese CC5 isolate N315. All other VRSA strains possess a truncating frameshift mutation predicted to generate a premature
termination, and possibly overlapping reinitiation product, as generically designated in the figure as VRSAa and VRSAb.
Vancomycin-Resistant Staphylococcus aureus
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(44). CC5 genomes possess a significantly larger set of lipoprotein
genes than non-CC5 genomes (P  0.05 by the Mann-Whitney
U test; see Fig. S4 in the supplemental material), suggesting that
selection favors their occurrence in these hospital isolates. We
observed strong congruence between lipoprotein- and whole-
genome-based phylogenies, showing that lipoprotein variation
largely parallels chromosome divergence patterns. Interestingly,
BLAST identified Listeria grayii as the only nonstaphylococcal
species possessing highly related homologs of S. aureus lipopro-
teins (1e24). Gram-positive bacteria process lipoprotein sig-
nal peptides into septa- or octapeptide pheromones (45), which
have been hypothesized to contribute acquisition of vancomycin
resistance by staphylococci (46). Potential pheromone sequences
encoded by the North American CC5 S. aureus genomes were
identified (Fig. S4).
DISCUSSION
MRSA emerged in the early 1960s and remained largely restricted
to the hospital environment (43). Not until resistance occurred in
other lineages 30 years later did it rapidly spread in the community
(43). CC5 is often the first lineage in which new antibiotic resis-
tance genes appear (10, 11, 47). Our work provides quantitative
support for an earlier proposition, based largely on PFGE (15–17),
that each occurrence of Tn1546-conferred vancomycin resistance
in S. aureus represents an independent acquisition, rather than
patient-to-patient spread. Modeling evolutionary distances on a
time scale (Fig. 6) shows that the last common ancestor of all
VRSA strains occurred at about the time of methicillin introduc-
tion, about 1960, 40 years earlier than vancomycin resistance was
found to have entered the species. The early 1960s also is the ap-
proximate time when the Japanese CC5 isolates diverged. The
modeling analysis employed was based on a calculated mutation
rate of 3.46  106 per site per year and employed conservative,
relaxed-clock assumptions. This rate is in excellent agreement
with the 3.3 106 0.7 106 mutation rate calculated inde-
pendently by others in a rigorous application of second-
generation sequencing in a study of the global spread of theMRSA
lineage ST239 that is prominent in Asia (48). Only in the case of
strains VRS11a and VRS11b, which were isolated from the same
patient, does the uncertainty with respect to the time of strain
divergence extend beyond the date of isolation of that VRSA
strain. The 1960 time point represents the time when the most
divergent VRSA strain, VRS3b (PFGE type USA800), branched
from the rest, most being USA100 PFGE type (Fig. 5). Within the
USA100 group, extensive diversification occurred next in about
1978.
In contrast to expectations, VRSA restriction barriers appear to
be largely intact. Strain VRS3a possesses a defect in the Sau1 en-
donuclease that is likely to be of functional consequence. How-
ever, most other polymorphisms in the Sau1 system were limited
to the Sa-encoded copy of a modification gene, with the Sa-
encoded copy fully intact. Another strain, VRS10, possesses
change in the type III-like restriction, shortening the predicted
primary translation product from 953 amino acids to 856 amino
acids by removal of the amino terminus. The functional conse-
quence of this truncation is currently unknown. It may be impor-
tant that all VRSA strains, except for the phylogenetic outlier
strain VRS3a, possess a nonsense mutation early in the dprA gene
FIG 5 Variation in the SA island of VRSA strains compared to other lineages. The gray shading for the schematic representations of the SA islands shown
to the right of the figure corresponds to the position within the phylogeny showing the relationship of VRSA genomes to other completely sequenced S. aureus
genomes shown to the left of the figure. The asterisk in the top right-hand corner of the schematic representation in panel b indicates that S. aureusCOL contains
an IS1811 transposase upstream of bsaA2. The pair of asterisks in the top right-hand corner of the schematic representation in panel d indicate that the far right
endpoint for RF122 is not shown because of phage insertion.
Kos et al.
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that is predicted to truncate a majority of the polypeptide. DprA
(also known as Smf [49]), is highly conserved and contributes to
efficient DNA transformation in naturally competent bacteria
(29, 49–54). Transformation efficiency of plasmids in a B. subtilis
dprA mutant is decreased 60-fold (29). Experiments with Esche-
richia coli dprAmutants do not show an obvious role in transfor-
mation or conjugation (55). Its function in S. aureus remains to be
explored.
Themost variable feature of the VRSA genome is plasmid con-
tent. In all cases, Tn1546 resides on a plasmid, even though it
clearly transposed upon entry into some strains, and because of
size, the chromosome would seem to be the most probable target
for transposon insertion. The basis for the insertion site prefer-
ence for plasmids over the S. aureus chromosome, and also for an
apparent incompatibility between the enterococcal Inc18 plasmid
that played a major role in the Michigan outbreak and an endog-
enous S. aureus pSK41 plasmid present in several recipients, is
unknown. VRSA genomes are replete with plasmids of enterococ-
cal origin, highlighting their cooccurrence in polymicrobic infec-
tions and possibly in other ecologies. The multiplicity of plasmid
structures conveying Tn1546, including S. aureus/enterococcal
cointegrate plasmids, increases the odds of future transfers, pos-
sibly into staphylococcal lineages or species where a lower fitness
cost is incurred.
The genomic island Sa is a distinguishing feature of CC5. Of
potential ecological importance, the bsa operon usually encoded
within this island is absent in VRSA and other CC5 strains. Fre-
quent application of antibiotics in the hospital environment may
select for strains with an enhanced ability to comingle with poten-
tial resistance donors of other species. Interestingly, this trait is
also lacking in otherwise highly divergent strains that are prevalent
in hospitals in the United Kingdom. The fact that United King-
dom and U.S. hospital strains with widely different chromosomal
backgrounds share very similar Sa islands suggests that there
may be active selection for this configuration in the hospital envi-
ronment. Multidrug-resistant enterococci are much more likely
to lack clustered regularly interspaced short palindromic repeat
(CRISPR) defenses of the genome than commensal strains (56),
indicating that the widespread use of antibiotics has selected for
hospital-adapted bacteria that have enhanced abilities to exist in
mixed communities and exchange resistance determinants. Loss
of bacteriocin production as well as immunity may also explain
why, for 30 years, CC5 MRSA strains were not able to establish
methicillin resistance in the community at a high level. They may
have been inhibited by the functional bacteriocin loci of S. aureus
strains of other sequence types (such as CC8 and CC1) already
present in the community niche. This may also be limiting the
spread of vancomycin resistance fromCC5 strains to other clades.
Staphylococcal enterotoxins, T cell mitogen superantigens (57)
that dysregulate the host response by stimulating CD8 regulatory T
cells (Tregs) at low concentrations (58) and other mechanisms, are
particularly abundant in the CC5 Sa element, as well as that of the
FIG 6 Consensus tree for CC5 under relaxed clock conditions. North American CC5 strains are shown in black, while other strains are shown in gray. Blue bars
indicate range of 95% highest posterior density interval (95% confidence interval, 1.76  106 to 5.22  106). The time of penicillin and methicillin
introduction, as well as the emergence of resistances are shown for reference (PRSA, penicillin-resistant S. aureus). The arrow indicates the estimated time of
divergence of the most distantly related VRSA genome, that of VRS3a (USA800 branch) from the remaining VRSA (mainly USA100) branch of the CC5 clade,
showing that strain divergence occurred far earlier than vancomycin resistance acquisition, supporting the model of independent Tn1546 acquisition.
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UnitedKingdomclones that are prevalent in hospitals. Enterotoxins,
togetherwith lipoproteins (59) and leukocidin (41, 42)may facilitate
overgrowth of mixed populations of bacteria at a site of infection,
contributing to the creation of conditions favorable for resistance
transfer.Notably,mostVRSA strains occurred inmixed infections of
plantar ulcers of diabetic patients (2), infections that are known to be
highly polymicrobic (60, 61).
The hospital is a unique environment, where colonization and
patient-to-patient propagation of a strainmay depend less on bac-
terial virulence traits associated with transmission (62) than on
transmission vectors in the form of hospital staff and environ-
mental surfaces and antibiotics (63). Strains that are prevalent in
hospitals are under continuous antibiotic selection pressure and
are exposed to an ever rotating arsenal. CC5 isolates appear to be
very well adapted for surviving and evolving in this environment
by acquiring resistance to new antibiotics.
MATERIALS AND METHODS
Strains. All available VRSA strains were obtained through the Network
of Antimicrobial Resistance in Staphylococcus aureus (NARSA) (see Table
S1B in the supplemental material). Since strain VRS3a is believed to be
identical to strain VRS3b, the latter was not sequenced. Strains VRS11b
andVRS11a had not been characterized, and bothwere examined because
of differences in oxacillin resistance. The VRSA strains were routinely
grown on tryptic soy agar containing 10 g/ml vancomycin.
Genome sequencing. For Illumina sequencing, total DNA was puri-
fied from 10-ml overnight cultures using the DNeasy DNA extraction kit
(Qiagen).DNAwas transferred to theTuftsUniversityDNACore Facility,
Boston, MA, and a modified Illumina protocol (64) was used. Libraries
were subjected to multiplexed paired-end sequencing according to the
manufacturer’s specifications. Sequencing reads were filtered to exclude
reads with a quality score of25 at any position. The average coverage of
the 3-Mb genomes was110-fold. The genomes were also independently
sequenced at the University at Buffalo Next-Generation Sequencing and
Expression Analysis Core (Buffalo, NY), by 454 FLX (Roche) to at least
10-fold coverage.
Assemblies. Illumina reads were assembled using Velvet version
1.0.18 (65). The 454 and Illumina reads were then combined and assem-
bled using Newbler 2.3 (Roche). Gene annotations were generated using
the Prodigal gene caller (66). Draft genomes for strains were submitted to
GenBank under the following accession numbers: strain VRS1,
AHBK00000000; VRS2, AHBL00000000; VRS3a, AHBM00000000;
VRS4, AHBN00000000; VRS5, AHBO00000000; VRS6, AHBP00000000;
VRS7, AHBQ00000000; VRS8, AHBR00000000; VRS9, AHBS00000000;
VRS10, AHBT00000000; VRS11a, AHBU00000000; and VRS11b,
AHBV00000000. The complete genomes of S. aureus strains used for com-
parison (see Table S1C in the supplemental material) were downloaded
from GenBank (http://www.ncbi.nlm.nih.gov) and the Sanger website
(http://www.sanger.ac.uk/pathogens).
PCR and targeted DNA sequencing. To verify results in some cases or
to obtain missing sequence information, PCR was performed using Taq
polymerase (New England Biolabs) with the amplification primers listed
in Table S4 in the supplemental material. DNA sequencing of individual
PCR products was performed by the Massachusetts General Hospital
DNA Sequencing Core Facility. Specific nucleotide sequence alignments
were routinely performed using mafft (67) and ClustalW (68).
Bioinformatic analysis. See Text S1 in the supplemental material.
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